. 2011 Mar 8;8(2):274–282. doi: 10.1007/s13311-011-0025-5

Table 1.

“Spinal Cord Injury” and “Spasticity” and “Pharmacological” www.clinicaltrials.gov

Treatment	Title of Trial	Primary outcome (study type)	Clinical phase status
Baclofen (Programmable implantable pump)	Continuous intrathecal baclofen infusion for the management of chronic spasticity	Muscle spasticity (interventional)	Phase III not yet recruiting
Baclofen (Programmable implantable pump)	https://www.clinicaltrials.gov/ct2/show/NCT01051128?term=spinal+cord+injury+AND+spasticity&recr=Open&rank=10	Muscle spasticity (interventional)	Phase III not yet recruiting
Cannabinoids (nabilone)	Effect of cannabinoids on spasticity in spinal cord injured persons	Muscle spasticity (interventional)	Phase II not yet recruiting
Cannabinoids (nabilone)	https://www.clinicaltrials.gov/ct2/show/NCT01222468?term=spinal+cord+injury+AND+spasticity&recr=Open&rank=2	Muscle spasticity (interventional)	Phase II not yet recruiting
Pregabalin (Lyrica) - Pfizer, New York City, NY	Study of pregabalin in the prevention of central neuropathic pain in acute spinal cord injury	Neuropathic pain and muscle spasticity (interventional)	Phase III not yet recruiting
Pregabalin (Lyrica) - Pfizer, New York City, NY	https://www.clinicaltrials.gov/ct2/show/NCT00879021?term=spinal+cord+injury+AND+spasticity&recr=Open&rank=7	Neuropathic pain and muscle spasticity (interventional)	Phase III not yet recruiting

SCI = spinal cord injury.